Welcome to Pulmozyme® Access Solutions™

At Genentech, we develop medicines like Pulmozyme® (dornase alfa) for serious or life-threatening medical conditions and we believe they should be accessible for the patients who need them.

Health insurance coverage and reimbursement issues can be confusing and challenging. Pulmozyme Access Solutions is here to make the process as easy as possible.

Please select one of the following so that we can direct you to information that is most appropriate for you.

  • Pulmozyme Access Solutions for Patients/Caregivers
  • Pulmozyme Access Solutions for HCPs


Please note: This description is provided for informational purposes only. The submission and completion of reimbursement- or coverage-related documentation are the responsibility of the patient and health care provider. Genentech, Inc. makes no representation or guarantees concerning reimbursement or coverage for any service or item.